Oxytocin prolongs the gastric emptying time in patients with diabetes mellitus and gastroparesis, but does not affect satiety or volume intake in patients with functional dyspepsia

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Borg, Julia ^a   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Diabetes mellitus; Functional dyspepsia; Gastric emptying scintigraphy; Gastroparesis; Slow satiety drinking test

Indexed keywords

GASTROINTESTINAL AGENT; OXYTOCIN; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DYSPEPSIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAL; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SATIETY; SCINTISCANNING; STOMACH; STOMACH EMPTYING; STOMACH PARESIS;

ADOLESCENT; ADULT; AREA UNDER CURVE; DIABETES MELLITUS; DYSPEPSIA; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MEALS; MIDDLE AGED; OXYTOCIN; SATIATION; SATIETY RESPONSE; SODIUM CHLORIDE; STOMACH; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84858253036     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-148     Document Type: Article

References (43)

1. Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study. Monstein HJ, Grahn N, Truedsson M, Ohlsson B, Regul Pept 2004 119 39 44 10.1016/j.regpep.2003.12.017 15093695 (Pubitemid 38482100)
2. Oxytocin is expressed throughout the human gastrointestinal tract. Ohlsson B, Truedsson M, Djerf P, Sundler F, Regul Pept 2006 135 7 11 10.1016/j.regpep.2006.03.008 16678285 (Pubitemid 43816098)
3. Cholecystokinin stimulation leads to increased oxytocin secretion in women. Ohlsson B, Forsling ML, Rehfeld JF, Sjolund K, Eur J Surg 2002 168 114 118 10.1080/11024150252884340 12113268 (Pubitemid 34478216)
4. Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia. Borg J, Melander O, Johansson L, Uvnas-Moberg K, Rehfeld JF, Ohlsson B, BMC Gastroenterol 2009 9 17 10.1186/1471-230X-9-17 19243587
5. The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. Ohlsson B, Bjorgell O, Ekberg O, Darwiche G, BMC Gastroenterol 2006 6 11 10.1186/1471-230X-6-11 16542457
6. Prolonged post-vagotomy gastric atony treated by oxytocin. Hashmonai M, Torem S, Argov S, Barzilai A, Schramek A, Br J Surg 1979 66 550 551 10.1002/bjs.1800660809 486913 (Pubitemid 10097538)
7. The effect of oxytocin on basal and pethidine-induced delayed gastric emptying. Petring OU, Br J Clin Pharmacol 1989 28 329 332 2789927
8. Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects. Borg J, Simren M, Ohlsson B, Neurogastroenterol Motil 2011 23 56 61 10.1111/j.1365-2982.2010.01599.x 20868426
9. LiCl and CCK inhibit gastric emptying and feeding and stimulate OT secretion in rats. McCann MJ, Verbalis JG, Stricker EM, Am J Physiol 1989 256 463 R468 2537039
10. Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety. Verbalis JG, McCann MJ, McHale CM, Stricker EM, Science 1986 232 1417 1419 10.1126/science.3715453 3715453 (Pubitemid 16059395)
11. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats. Wu CL, Hung CR, Chang FY, Pau KY, Wang JL, Wang PS, Pflugers Arch 2002 445 187 193 10.1007/s00424-002-0925-7 12457239 (Pubitemid 35447513)
12. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats. Wu CL, Hung CR, Chang FY, Pau KY, Wang PS, Naunyn Schmiedebergs Arch Pharmacol 2003 367 406 413 10.1007/s00210-003-0690-y 12690433 (Pubitemid 36535309)
13. Oxytocin receptor expressed on the smooth muscle mediates the excitatory effect of oxytocin on gastric motility in rats. Qin J, Feng M, Wang C, Ye Y, Wang PS, Liu C, Neurogastroenterol Motil 2009 21 430 438 10.1111/j.1365-2982. 2009.01282.x 19309416
14. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Tack J, Caenepeel P, Piessevaux H, Cuomo R, Janssens J, Gut 2003 52 1271 1277 10.1136/gut.52.9.1271 12912857 (Pubitemid 37026458)
15. Prokinetics and fundic relaxants in upper functional GI disorders. Tack J, Curr Opin Pharmacol 2008 8 690 696 10.1016/j.coph.2008.09.009 18940266
16. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association, Gastroenterology 2004 127 1592 1622 10.1053/j.gastro.2004.09.055 15521026 (Pubitemid 39457783)
17. Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Faraj J, Melander O, Sundkvist G, Olsson R, Thorsson O, Ekberg O, Ohlsson B, Diabet Med 2007 24 1235 1239 10.1111/j.1464-5491.2007.02236.x 17725632 (Pubitemid 47621799)
18. Diabetic gastroparesis. Kong MF, Horowitz M, Diabet Med 2005 22 Suppl 4 13 18 16109013 (Pubitemid 41224164)
19. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Norton NJ, Hamilton F, Neurogastroenterol Motil 2010 22 113 133 10.1111/j.1365-2982.2009.01434.x 20003077
20. The central organization of the vagus nerve innervating the stomach of the rat. Shapiro RE, Miselis RR, J Comp Neurol 1985 238 473 488 10.1002/cne.902380411 3840183 (Pubitemid 15003782)
21. Gastric afferents to the paraventricular nucleus in the rat. Ueta Y, Kannan H, Yamashita H, Exp Brain Res 1991 84 487 494 1864321
22. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Ermisch A, Barth T, Ruhle HJ, Skopkova J, Hrbas P, Landgraf R, Endocrinol Exp 1985 19 29 37 3872788 (Pubitemid 15062320)
23. Gastric motility in conscious rats given oxytocin and an oxytocin antagonist centrally. Flanagan LM, Olson BR, Sved AF, Verbalis JG, Stricker EM, Brain Res 1992 578 256 260 10.1016/0006-8993(92)90255-8 1324762
24. Basic and clinical pharmacology of new motility promoting agents. Galligan JJ, Vanner S, Neurogastroenterol Motil 2005 17 643 653 10.1111/j.1365-2982.2005.00675.x 16185302 (Pubitemid 41400712)
25. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Schwizer W, Borovicka J, Kunz P, Fraser R, Kreiss C, D'Amato M, Crelier G, Boesiger P, Fried M, Gut 1997 41 500 504 10.1136/gut.41.4.500 9391249 (Pubitemid 27448782)
26. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Feinle C, Meier O, Otto B, D'Amato M, Fried M, Gut 2001 48 347 355 10.1136/gut.48.3.347 11171824 (Pubitemid 32269562)
27. The CCK1 receptor antagonist dexloxiglumide is effective and safe in female patients with constipation predominant irritable bowel syndrome. D'Amato W, Thompson DG, Spiller RC, Giacovelli G, Griffin PH, Schneier H, Lucio RC, Am J Gastroenterol 2001 96 317
28. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjölund K, Björnsson ES, Simrèn M, Neurogastroenterol Motil 2005 17 697 704 10.1111/j.1365-2982.2005.00679.x 16185308 (Pubitemid 41400718)
29. Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K, Neurosci Lett 1996 212 87 90 10.1016/0304-3940(96)12773-7 8832645 (Pubitemid 26301129)
30. Functional gastroduodenal disorders. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V, Gastroenterology 2006 130 1466 1479 10.1053/j.gastro.2005.11.059 16678560
31. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agréus L, Clin Gastroenterol Hepatol 2007 5 1175 1183 10.1016/j.cgh.2007.05.015 17686660 (Pubitemid 47488962)
32. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Friesen CA, Lin Z, Singh M, Singh V, Schurman JV, Burchell N, Cocjin JT, McCallum RW, Dig Dis Sci 2008 53 2634 2640 10.1007/s10620-008-0207-0 18320315
33. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Karamanolis G, Caenepeel P, Arts J, Tack J, Gastroenterology 2006 130 296 303 10.1053/j.gastro.2005.10. 019 16472585 (Pubitemid 43202029)
34. Mechanisms of hypersensitivity in IBS and functional disorders. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC, Neurogastroenterol Motil 2007 19 62 88 10.1111/j.1365-2982.2006.00875.x 17280586 (Pubitemid 46058983)
35. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Camilleri M, Gastroenterol Clin North Am 2007 36 649 664 10.1016/j.gtc.2007.07.001 17950442 (Pubitemid 47575837)
36. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. Talley NJ, Choung RS, J Gastroenterol Hepatol 2009 24 Suppl 3 20 28
37. Role of impaired gastric accommodation to a meal in functional dyspepsia. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J, Gastroenterology 1998 115 1346 1352 10.1016/S0016-5085(98)70012-5 9834261 (Pubitemid 28545984)
38. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER, Gut 2010 59 489 495 10.1136/gut.2008.175000 19651629
39. Daily variation in gastric emptying when using the double sampling technique. Beckers EJ, Rehrer NJ, Saris WH, Brouns F, Ten Hoor F, Kester AD, Med Sci Sports Exerc 1991 23 1210 1212 1758298
40. Gastric emptying in diabetes: clinical significance and treatment. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M, Diabet Med 2002 19 177 194 10.1046/j.1464-5491.2002.00658.x 11918620 (Pubitemid 34429648)
41. The functional gastrointestinal disorders and the Rome III process. Drossman DA, Gastroenterology 2006 130 1377 1390 10.1053/j.gastro.2006.03.008 16678553
42. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer H-M, the IFCC working group on HbA1c standardization, Clin Chem 2004 50 166 174 10.1373/clinchem.2003.024802 14709644 (Pubitemid 38125714)
43. Gastric emptying in smokers. Hanson M, Lilja B, Scand J Gastroenterol 1987 22 1102 1104 10.3109/00365528708991965 3423735 (Pubitemid 17157005)